Myeloid Leukemia

Real-Time RT-PCR Strategies 65
21. Letertre, C., Perelle, S., Dilasser, F., Arar, K., and Fach, P.. (2003) Evaluation of
the performance of LNA and MGB probes in 5�-nuclease PCR assays. Mol. Cell.
Probes 17, 307–311.
22. Wittwer, C. T., Ririe, K. M., Andrew, R. V., David, D. A., Gundry, R. A., and
Balis, U. J. (1997b) The LightCycler: a microvolume multisample fluorimeter
with rapid temperature control. Biotechniques 22, 176–181.
23. Meuer, S. Wittwer, C., and Nakagawara, K. (eds) (2001) Rapid Cycle Real-Time
PCR: Methods and Applications. Springer, Heidelberg.
24. Tyagi, S. and Kramer, F. R. (1996) Molecular beacons: probes that fluoresce upon
hybridization. Nat. Biotechnol. 14, 303–308.
25. Leone, G., van Schijndel, H., van Gemen, B., Kramer, F. R., and Schoen, C. D.
(1998) Molecular beacon probes combined with amplification by NASBA enable
homogeneous, real-time detection of RNA. Nucleic Acids Res. 26, 2150–2155.
26. Whitcombe, D., Theaker, J., Guy, S. P., Brown, T., and Little, S. (1999) Detection
of PCR products using self-probing amplicons and fluorescence. Nat. Biotechnol.
17, 804–807.
27. Thelwell, N., Millington, S., Solinas, A., Booth, J., and Brown, T. (2000) Mode of
action and application of Scorpion primers to mutation detection. Nucleic Acids
Res. 28, 3752–3761.
28. Solinas, A., Brown, L. J., McKeen, C., et al. (2001) Duplex Scorpion primers in
SNP analysis and FRET applications. Nucleic Acids Res. 29, E96.
28a. Silvy, M., Mancini, J., Thirion, X., Sigaux, F., and Gabert, J. (2005) Evaluation of
real-time quantitative PCR machines for the monitoring of fusion gene transcripts
using the Europe Against Cancer protocol. Leukemia 19, 305–307.
29. Pattyn, F., Speleman, F., De Paepe, A., and Vandesompele, J. (2003) RTPrimerDB:
the real-time PCR primer and probe database. Nucleic Acids Res. 31, 122–123.
30. Gabert, J., Beillard, E., van der Velden, V. H., et al. (2003) Standardization and
quality control studies of “real-time” quantitative reverse transcriptase polymerase
chain reaction of fusion gene transcripts for residual disease detection in leukemia—a
Europe Against Cancer program. Leukemia 17, 2318–2357.
31. Beillard, E., Pallisgaard, N. van der Velden, V. H., et al. (2003) Evaluation of
candidate control genes for diagnosis and residual disease detection in leukemic
patients using “real-time” quantitative reverse-transcriptase polymerase chain reaction
(RQ-PCR)—a Europe against cancer program. Leukemia 17, 2474–2486.
32. Freeman, W. M., Walker, S. J., and Vrana, K. E. (1999) Quantitative RT-PCR:
pitfalls and potential. Biotechniques 26, 112–122, 124–125.
33. Keilholz, U., Willhauck, M., Rimoldi, D., et al. (1998) Reliability of reverse transcription-polymerase
chain reaction (RT-PCR)-based assays for the detection of
circulating tumour cells: a quality-assurance initiative of the EORTC Melanoma
Cooperative Group. Eur. J. Cancer 34, 750–753.
34. Bolufer, P., Lo Coco, F., Grimwade, D., et al. (2001) Variability in the levels of
PML-RAR alpha fusion transcripts detected by the laboratories participating in an
external quality control program using several reverse transcription polymerase
chain reaction protocols. Haematologica 86, 570–576.